C. difficile: Oral fecal microbiota, Vowst, receives FDA nod
by Press Release from Outbreak News Today on (#6B9WG)
NewsDesk @bactiman63 On Wednesday, the U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally. Vowst is approved for the prevention of recurrence of Clostridioides difficile (C. difficile) infection (CDI) in individuals 18 years of age and older, following antibacterial treatment for recurrent CDI. Today's approval provides patients and healthcare providers a new [...]
The post C. difficile: Oral fecal microbiota, Vowst, receives FDA nod appeared first on Outbreak News Today.